Plp1jp-4J/Y
involves: C3H/HeJ * C57BL/6J
|
abnormal CNS glial cell morphology |
J:36181
|
astrocytosis |
J:36181
|
decreased oligodendrocyte number |
J:41569
|
demyelination |
J:36181,
J:41569
|
lethality at weaning, complete penetrance |
J:41569
|
seizures |
J:41569
|
tremors |
J:41569
|
Plp1jp-6J/Y
BALB/cJ-Plp1jp-6J/GrsrJ
|
asthenozoospermia |
J:236909
|
oligozoospermia |
J:236909
|
premature death |
J:236909
|
tremors |
J:236909
|
Plp1jp-msd/Y
B6C3-EdaTa Plp1jp-msd
|
decreased body weight |
J:7157
|
demyelination |
J:7157
|
tremors |
J:7157
|
Plp1jp-msd/Y
involves: BALB/c * C3H * C57BL/6 * C57BL/10
|
increased apoptosis |
J:121540
|
premature death |
J:121540
|
Plp1jp-msd/Y
involves: BALB/c * C57BL/6J * C57BL/10
|
abnormal myelination |
J:159450
|
premature death |
J:159450
|
Plp1jp-msd/Y
involves: C57BL/10Sn * BALB/cJ
|
abnormal myelination |
J:5170
|
demyelination |
J:5170
|
postnatal lethality, complete penetrance |
J:5170
|
seizures |
J:5170
|
tremors |
J:5170
|
Plp1jp-msd/Plp1jp-msd
involves: BALB/c * C57BL/6J * C57BL/10
|
abnormal myelination |
J:159450
|
premature death |
J:159450
|
Plp1jp-rsh/Y
C3H * C57BL/6 * STOCK Rb(1.3)1Bnr
|
abnormal myelin sheath morphology |
J:31089
|
demyelination |
J:31089
|
Plp1jp-rsh/Plp1+
either: STOCK Rb(1.3)1Bnr or (involves: BALB/c * DBA/2 * STOCK Rb(1.3)1Bnr)
|
abnormal microglial cell morphology |
J:604
|
abnormal myelination |
J:604
|
abnormal oligodendrocyte morphology |
J:604
|
demyelination |
J:604
|
increased oligodendrocyte number |
J:604
|
Plp1jp-rsh/Y
involves: 101 * C3H
|
abnormal astrocyte morphology |
J:10575
|
abnormal axonal transport |
J:229229
|
abnormal brain development |
J:88023
|
abnormal glial cell morphology |
J:88023
|
astrocytosis |
J:88023
|
normal
behavior/neurological phenotype |
J:14143
|
demyelination |
J:10575,
J:14143,
J:88023
|
dysmyelination |
J:229229
|
normal
growth/size/body region phenotype |
J:14143
|
impaired coordination |
J:88023
|
increased oligodendrocyte number |
J:10575
|
normal
reproductive system phenotype |
J:14143
|
tremors |
J:10575,
J:14143,
J:88023
|
Plp1jp-rsh/Y
involves: C3H * C57BL/6 * STOCK Rb(1.3)1Bnr
|
abnormal locomotor coordination |
J:121540
|
increased apoptosis |
J:121540
|
Plp1jp-rsh/Y
involves: C57BL/6NCrl
|
abnormal brain development |
J:88023
|
abnormal glial cell morphology |
J:88023
|
astrocytosis |
J:88023
|
decreased body weight |
J:88023
|
decreased locomotor activity |
J:88023
|
demyelination |
J:88023
|
impaired coordination |
J:88023
|
premature death |
J:88023
|
seizures |
J:88023
|
tremors |
J:88023
|
Plp1jp-rsh/Plp1jp-rsh
C3H * C57BL/6 * STOCK Rb(1.3)1Bnr
|
abnormal myelin sheath morphology |
J:31089
|
abnormal phospholipid level |
J:31089
|
Plp1jp-rsh/Plp1jp-rsh
involves: 101 * C3H
|
abnormal astrocyte morphology |
J:10575
|
normal
behavior/neurological phenotype |
J:14143
|
demyelination |
J:10575,
J:14143
|
normal
growth/size/body region phenotype |
J:14143
|
increased oligodendrocyte number |
J:10575
|
normal
reproductive system phenotype |
J:14143
|
tremors |
J:10575,
J:14143
|
Plp1jp-rsh/Plp1jp-rsh
involves: 101/H * C3H
|
decreased susceptibility to Picornaviridae infection |
J:41447
|
Plp1jp/Y
B6C3-EdaTa Plp1jp
|
abnormal myelination |
J:7157
|
decreased body weight |
J:7157
|
demyelination |
J:7157
|
premature death |
J:7157
|
tremors |
J:7157
|
Plp1jp/Y
B6CB-Aw-J/A EdaTa Plp1jp
|
abnormal astrocyte physiology |
J:116364
|
abnormal myelination |
J:5611,
J:160743
|
abnormal oligodendrocyte morphology |
J:5611
|
abnormal startle reflex |
J:18363
|
decreased body weight |
J:18363
|
decreased locomotor activity |
J:18363
|
decreased oligodendrocyte number |
J:5611
|
decreased vocalization |
J:18363
|
delayed eyelid opening |
J:18363
|
Plp1jp/Plp1+
B6CB-Aw-J/A EdaTa Plp1jp
|
astrocytosis |
J:6895
|
Plp1jp/Y
Not Specified
|
abnormal astrocyte morphology |
J:159601
|
abnormal brain morphology |
J:13141
|
abnormal brain white matter morphology |
J:13141
|
abnormal myelin sheath morphology |
J:159601
|
abnormal myelination |
J:13141
|
abnormal oligodendrocyte morphology |
J:159601
|
environmentally induced seizures |
J:288
|
hindlimb paralysis |
J:13141
|
paraparesis |
J:13141
|
premature death |
J:288,
J:13141
|
tonic-clonic seizures |
J:13141
|
tremors |
J:288,
J:13141
|
Plp1tm1.1Blyg/Y
involves: 129S6/SvEvTac * C57BL/6J * FVB/N
|
normal
nervous system phenotype |
J:193537
|
Plp1tm1.1Gow/Y
Not Specified
|
abnormal cerebellar granule layer morphology |
J:62287
|
abnormal cerebellum morphology |
J:62287
|
abnormal cerebellum white matter morphology |
J:62287
|
abnormal myelination |
J:62287
|
axon degeneration |
J:62287
|
axonal spheroids |
J:62287
|
demyelination |
J:62287
|
gliosis |
J:62287
|
impaired coordination |
J:62287
|
neurodegeneration |
J:62287
|
Plp1tm1c(EUCOMM)Wtsi/Y Cnptm1(cre)Kan/Cnp+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6N
|
abnormal hippocampal fimbria morphology |
J:245100
|
astrocytosis |
J:245100
|
axonal spheroids |
J:245100
|
increased T cell number |
J:245100
|
microgliosis |
J:245100
|
Plp1tm1c(EUCOMM)Wtsi/Y Neurod6tm1(cre)Kan/Neurod6+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6N
|
normal
nervous system phenotype |
J:245100
|
Plp1tm1Frca/Y
B6.129-Plp1tm1Frca
|
abnormal myelin sheath morphology |
J:143305
|
axon degeneration |
J:143305
|
normal
behavior/neurological phenotype |
J:143305
|
demyelination |
J:143305
|
impaired coordination |
J:143305
|
Plp1tm1Gow/Y
Not Specified
|
abnormal cerebellum white matter morphology |
J:62287
|
abnormal myelination |
J:62287
|
axon degeneration |
J:62287
|
axonal spheroids |
J:62287
|
demyelination |
J:62287
|
gliosis |
J:62287
|
impaired coordination |
J:62287
|
neurodegeneration |
J:62287
|
Plp1tm1Kan/Y
B6.129-Plp1tm1Kan
|
astrocytosis |
J:201143
|
axon degeneration |
J:201143
|
axonal spheroids |
J:201143
|
decreased body weight |
J:201143
|
demyelination |
J:201143
|
hindlimb paralysis |
J:201143
|
kyphosis |
J:201143
|
microgliosis |
J:201143
|
Plp1tm1Kan/Y
B6N.129-Plp1tm1Kan
|
axonal spheroids |
J:236408
|
dysmyelination |
J:236408
|
tomacula |
J:236408
|
Plp1tm1Kan/Y
involves: 129S1/Sv * 129X1/SvJ
|
abnormal axon morphology |
J:48031
|
abnormal gait |
J:48031
|
abnormal hippocampal fimbria morphology |
J:245100
|
abnormal locomotor coordination |
J:48031
|
abnormal microglial cell morphology |
J:48031
|
abnormal myelin sheath morphology |
J:48031,
J:193310
|
abnormal oligodendrocyte morphology |
J:48031,
J:106182
|
astrocytosis |
J:48031,
J:245100
|
axonal spheroids |
J:245100
|
decreased cholesterol level |
J:193310
|
demyelination |
J:48031
|
impaired coordination |
J:48031
|
microgliosis |
J:245100
|
Plp1tm1Kan/Plp1+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal axon morphology |
J:48031
|
Plp1tm1Kan/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal axon morphology |
J:146665
|
abnormal myelin sheath morphology |
J:146665
|
ataxia |
J:146665
|
axon degeneration |
J:146665
|
paraparesis |
J:146665
|
Plp1tm1Kan/Y
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
abnormal myelin sheath morphology |
J:38856
|
axonal spheroids |
J:38856
|
normal
behavior/neurological phenotype |
J:38856
|
Plp1tm1Wst/Plp1+
involves: 129P2/OlaHsd
|
abnormal oligodendrocyte morphology |
J:21976
|
Plp1tm1Wst/Plp1tm1Wst
involves: 129P2/OlaHsd
|
abnormal axon morphology |
J:105188
|
abnormal myelin sheath morphology |
J:105188
|
abnormal myelination |
J:21976,
J:105188
|
abnormal nerve conduction |
J:21976
|
abnormal oligodendrocyte morphology |
J:21976
|
axonal spheroids |
J:105188
|
decreased locomotor activity |
J:21976
|
impaired coordination |
J:21976
|
Plp1tm2Wst/Plp1+
involves: 129P2/OlaHsd
|
abnormal oligodendrocyte morphology |
J:21976
|
Plp1tm2Wst/Plp1tm2Wst
involves: 129P2/OlaHsd
|
abnormal myelination |
J:21976
|
abnormal nerve conduction |
J:21976
|
abnormal oligodendrocyte morphology |
J:21976
|
decreased locomotor activity |
J:21976
|
impaired coordination |
J:21976
|
Plp1tm3Wst/Plp1tm3Wst
B6.129S1-Plp1tm3Wst
|
abnormal myelin sheath morphology |
J:105188
|
abnormal myelination |
J:105188
|
abnormal optic nerve morphology |
J:105188
|
Tg(Plp)66Kan/0
B6NCrl.Cg-Tg(Plp)66Kan
|
abnormal myelin sheath morphology |
J:156106
|
ataxia |
J:156106
|
axon degeneration |
J:156106
|
demyelination |
J:156106
|
kyphosis |
J:156106
|
weight loss |
J:156106
|
Tg(Plp)66Kan/Tg(Plp)66Kan
B6NCrl.Cg-Tg(Plp)66Kan
|
abnormal myelin sheath morphology |
J:156106
|
abnormal oligodendrocyte apoptosis |
J:156106
|
abnormal oligodendrocyte morphology |
J:156106
|
demyelination |
J:156106
|
premature death |
J:156106
|
seizures |
J:156106
|
tremors |
J:156106
|
Tg(Plp)66Kan/Tg(Plp)66Kan
involves: C57BL * DBA
|
astrocytosis |
J:17373
|
ataxia |
J:17373
|
demyelination |
J:17373
|
premature death |
J:17373
|
seizures |
J:17373
|
tremors |
J:17373
|
Tg(Plp)72Kan/Tg(Plp)72Kan
B6N.Cg-Tg(Plp)72Kan
|
abnormal axonal transport |
J:229229
|
abnormal cell cytoskeleton morphology |
J:229229
|
abnormal optic nerve morphology |
J:229229
|
abnormal optic tract morphology |
J:229229
|
decreased myelin sheath thickness |
J:229229
|
decreased nerve conduction velocity |
J:229229
|
demyelination |
J:229229
|
dysmyelination |
J:229229
|
Tg(Plp)72Kan/Tg(Plp)72Kan
involves: C57BL/6 * DBA
|
astrocytosis |
J:17373
|
dysmyelination |
J:17373
|
premature death |
J:17373
|